91 related articles for article (PubMed ID: 17290357)
1. Relevance of multidrug resistance 1 and P-glycoprotein to drug resistance in patients with systemic lupus erythematosus.
Tsujimura S; Saito K; Nakayamada S; Tanaka Y
Histol Histopathol; 2007 Apr; 22(4):465-8. PubMed ID: 17290357
[TBL] [Abstract][Full Text] [Related]
2. [Multi-drug resistance in the treatments of autoimmune diseases].
Tanaka Y; Tsujimura S
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Oct; 29(5):319-24. PubMed ID: 17075191
[TBL] [Abstract][Full Text] [Related]
3. Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease.
Tsujimura S; Tanaka Y
Clin Exp Nephrol; 2012 Feb; 16(1):102-8. PubMed ID: 21847519
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus.
Tsujimura S; Saito K; Nakayamada S; Nakano K; Tanaka Y
Arthritis Rheum; 2005 Jun; 52(6):1676-83. PubMed ID: 15934077
[TBL] [Abstract][Full Text] [Related]
5. Persistent expression and function of P-glycoprotein on peripheral blood lymphocytes identifies corticosteroid resistance in patients with systemic lupus erythematosus.
Kansal A; Tripathi D; Rai MK; Agarwal V
Clin Rheumatol; 2016 Feb; 35(2):341-9. PubMed ID: 26415739
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein in autoimmune diseases.
Richaud-Patin Y; Soto-Vega E; Jakez-Ocampo J; Llorente L
Autoimmun Rev; 2004 Mar; 3(3):188-92. PubMed ID: 15110230
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of multidrug resistance-1 gene by interleukin-2 in lymphocytes.
Tsujimura S; Saito K; Nakayamada S; Nakano K; Tsukada J; Kohno K; Tanaka Y
Genes Cells; 2004 Dec; 9(12):1265-73. PubMed ID: 15569157
[TBL] [Abstract][Full Text] [Related]
8. Overcoming treatment unresponsiveness mediated by P-glycoprotein overexpression on lymphocytes in refractory active systemic lupus erythematosus.
Tsujimura S; Saito K; Tokunaga M; Nakatsuka K; Nakayamada S; Nakano K; Tanaka Y
Mod Rheumatol; 2005; 15(1):28-32. PubMed ID: 17028818
[TBL] [Abstract][Full Text] [Related]
9. Disease control by regulation of P-glycoprotein on lymphocytes in patients with rheumatoid arthritis.
Tsujimura S; Tanaka Y
World J Exp Med; 2015 Nov; 5(4):225-31. PubMed ID: 26618109
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients.
Richaud-Patin Y; Vega-Boada F; Vidaller A; Llorente L
Biomed Pharmacother; 2004 Jun; 58(5):320-4. PubMed ID: 15194168
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
Willman CL
Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
[TBL] [Abstract][Full Text] [Related]
12. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: Increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control.
Diaz-Borjon A; Richaud-Patin Y; Alvarado de la Barrera C; Jakez-Ocampo J; Ruiz-Argüelles A; Llorente L
Joint Bone Spine; 2000 Jan; 67(1):40-8. PubMed ID: 10773967
[TBL] [Abstract][Full Text] [Related]
14. Increased multidrug resistance-associated protein activity in mononuclear cells of patients with systemic lupus erythematosus.
Lu MC; Lai NS; Li KJ; Hsieh SC; Wu CH; Yu CL
Clin Exp Rheumatol; 2008; 26(4):638-45. PubMed ID: 18799096
[TBL] [Abstract][Full Text] [Related]
15. IPEC-J2 MDR1, a Novel High-Resistance Cell Line with Functional Expression of Human P-glycoprotein (ABCB1) for Drug Screening Studies.
Saaby L; Helms HC; Brodin B
Mol Pharm; 2016 Feb; 13(2):640-52. PubMed ID: 26651362
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes.
Janneh O; Jones E; Chandler B; Owen A; Khoo SH
J Antimicrob Chemother; 2007 Nov; 60(5):987-93. PubMed ID: 17890284
[TBL] [Abstract][Full Text] [Related]
17. The network of P-glycoprotein and microRNAs interactions.
Lopes-Rodrigues V; Seca H; Sousa D; Sousa E; Lima RT; Vasconcelos MH
Int J Cancer; 2014 Jul; 135(2):253-63. PubMed ID: 24122334
[TBL] [Abstract][Full Text] [Related]
18. Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production.
Li B; Yue Y; Dong C; Shi Y; Xiong S
Clin Exp Rheumatol; 2014; 32(5):705-14. PubMed ID: 25151985
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of sorcin is associated with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
Yamagishi N; Nakao R; Kondo R; Nishitsuji M; Saito Y; Kuga T; Hatayama T; Nakayama Y
Biochem Biophys Res Commun; 2014 Jun; 448(4):430-6. PubMed ID: 24796664
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane P-glycoprotein (P-gp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function.
Lucia MB; Cauda R; Landay AL; Malorni W; Donelli G; Ortona L
AIDS Res Hum Retroviruses; 1995 Aug; 11(8):893-901. PubMed ID: 7492436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
